Clinical Trial

Neurostimulation for Sleep Disordered Breathing

Study acronym: ECLIPSE 1
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a first in human study to determine if the Lunair Alpha System is safe and effective for treating moderate to severe sleep disordered breathing.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-12.
Trial Details
NCT Number NCT06883617
Lead Sponsor Lunair Medical
Conditions Sleep Disordered Breathing (SDB), Sleep Apnea
Enrollment 45 participants
Start Date 2025-01-13
Primary Completion 2026-04-30 (estimated)
Study Completion 2027-12-15 (estimated)
Updated on ClinicalTrials.gov 2025-03-20